209 related articles for article (PubMed ID: 32062134)
1. An induced pluripotent stem cell line (SHEHi002-A (5426))from a patient of long QT syndrome type 8 with c.2573G>A mutation in the gene CACNA1C.
Zhou HM; Zhou XQ; Lu JZ; Jia WW; Kang JH
Stem Cell Res; 2020 Mar; 43():101731. PubMed ID: 32062134
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.
Estes SI; Ye D; Zhou W; Dotzler SM; Tester DJ; Bos JM; Kim CSJ; Ackerman MJ
Circ Genom Precis Med; 2019 Aug; 12(8):e002534. PubMed ID: 31430211
[TBL] [Abstract][Full Text] [Related]
3. Disrupted Ca
Kashiwa A; Makiyama T; Kohjitani H; Maurissen TL; Ishikawa T; Yamamoto Y; Wuriyanghai Y; Gao J; Huang H; Imamura T; Aizawa T; Nishikawa M; Chonabayashi K; Mishima H; Ohno S; Toyoda F; Sato S; Yoshiura KI; Takahashi K; Yoshida Y; Woltjen K; Horie M; Makita N; Kimura T
Heart Rhythm; 2023 Jan; 20(1):89-99. PubMed ID: 36007726
[TBL] [Abstract][Full Text] [Related]
4. Long QT syndrome type 8: novel CACNA1C mutations causing QT prolongation and variant phenotypes.
Fukuyama M; Wang Q; Kato K; Ohno S; Ding WG; Toyoda F; Itoh H; Kimura H; Makiyama T; Ito M; Matsuura H; Horie M
Europace; 2014 Dec; 16(12):1828-37. PubMed ID: 24728418
[TBL] [Abstract][Full Text] [Related]
5. Timothy syndrome iPSC modeling.
Bekdash R; Klein AD; Yazawa M
Mol Cell Neurosci; 2020 Sep; 107():103529. PubMed ID: 32629111
[TBL] [Abstract][Full Text] [Related]
6. Patient-independent human induced pluripotent stem cell model: A new tool for rapid determination of genetic variant pathogenicity in long QT syndrome.
Chavali NV; Kryshtal DO; Parikh SS; Wang L; Glazer AM; Blackwell DJ; Kroncke BM; Shoemaker MB; Knollmann BC
Heart Rhythm; 2019 Nov; 16(11):1686-1695. PubMed ID: 31004778
[TBL] [Abstract][Full Text] [Related]
7. Timothy syndrome-like condition with syndactyly but without prolongation of the QT interval.
Kosaki R; Ono H; Terashima H; Kosaki K
Am J Med Genet A; 2018 Jul; 176(7):1657-1661. PubMed ID: 29736926
[TBL] [Abstract][Full Text] [Related]
8. Generation of induced pluripotent stem cells (iPSCs) from a Chinese infant (XACHi015-A) with type 2 Long QT syndrome carrying the heterozygous mutation c.1814C>T(p.P605L) in KCNH2.
Wang T; Zhou Y; Zhou R; Huang W; Wang J; Li H; Lei M; Tan X; Zhang Y
Stem Cell Res; 2021 Oct; 56():102509. PubMed ID: 34438161
[TBL] [Abstract][Full Text] [Related]
9. Generation of three iPSC lines (XACHi007-A, XACHi008-A, XACHi009-A) from a Chinese family with long QT syndrome type 5 with heterozygous c.226G>A (p.D76N) mutation in KCNE1gene.
Zhang Y; Li H; Wang J; Wang G; Tan X; Lei M
Stem Cell Res; 2020 May; 45():101798. PubMed ID: 32344329
[TBL] [Abstract][Full Text] [Related]
10. Novel long QT syndrome-associated missense mutation, L762F, in CACNA1C-encoded L-type calcium channel imparts a slower inactivation tau and increased sustained and window current.
Landstrom AP; Boczek NJ; Ye D; Miyake CY; De la Uz CM; Allen HD; Ackerman MJ; Kim JJ
Int J Cardiol; 2016 Oct; 220():290-8. PubMed ID: 27390944
[TBL] [Abstract][Full Text] [Related]
11. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1.
Mura M; Bastaroli F; Corli M; Ginevrino M; Calabrò F; Boni M; Crotti L; Valente EM; Schwartz PJ; Gnecchi M
Stem Cell Res; 2020 Jan; 42():101658. PubMed ID: 31785541
[TBL] [Abstract][Full Text] [Related]
12. Generation of eight human induced pluripotent stem cell (iPSC) lines from familial Long QT Syndrome type 1 (LQT1) patients carrying KCNQ1 c.1697C>A mutation (NUIGi005-A, NUIGi005-B, NUIGi005-C, NUIGi006-A, NUIGi006-B, NUIGi006-C, NUIGi007-A, and NUIGi007-B).
Ge N; Liu M; Krawczyk J; McInerney V; Galvin J; Shen S; O'Brien T; Prendiville T
Stem Cell Res; 2019 Aug; 39():101502. PubMed ID: 31415974
[TBL] [Abstract][Full Text] [Related]
13. Gain-of-function mutations in the calcium channel CACNA1C (Cav1.2) cause non-syndromic long-QT but not Timothy syndrome.
Wemhöner K; Friedrich C; Stallmeyer B; Coffey AJ; Grace A; Zumhagen S; Seebohm G; Ortiz-Bonnin B; Rinné S; Sachse FB; Schulze-Bahr E; Decher N
J Mol Cell Cardiol; 2015 Mar; 80():186-95. PubMed ID: 25633834
[TBL] [Abstract][Full Text] [Related]
14. R534C mutation in hERG causes a trafficking defect in iPSC-derived cardiomyocytes from patients with type 2 long QT syndrome.
Mesquita FCP; Arantes PC; Kasai-Brunswick TH; Araujo DS; Gubert F; Monnerat G; Silva Dos Santos D; Neiman G; Leitão IC; Barbosa RAQ; Coutinho JL; Vaz IM; Dos Santos MN; Borgonovo T; Cruz FES; Miriuka S; Medei EH; Campos de Carvalho AC; Carvalho AB
Sci Rep; 2019 Dec; 9(1):19203. PubMed ID: 31844156
[TBL] [Abstract][Full Text] [Related]
15. Digenic Heterozigosity in SCN5A and CACNA1C Explains the Variable Expressivity of the Long QT Phenotype in a Spanish Family.
Nieto-Marín P; Jiménez-Jáimez J; Tinaquero D; Alfayate S; Utrilla RG; Rodríguez Vázquez Del Rey MDM; Perin F; Sarquella-Brugada G; Monserrat L; Brugada J; Tercedor L; Tamargo J; Delpón E; Caballero R
Rev Esp Cardiol (Engl Ed); 2019 Apr; 72(4):324-332. PubMed ID: 29691127
[TBL] [Abstract][Full Text] [Related]
16. Penetrance and expressivity of the R858H CACNA1C variant in a five-generation pedigree segregating an arrhythmogenic channelopathy.
Gardner RJM; Crozier IG; Binfield AL; Love DR; Lehnert K; Gibson K; Lintott CJ; Snell RG; Jacobsen JC; Jones PP; Waddell-Smith KE; Kennedy MA; Skinner JR
Mol Genet Genomic Med; 2019 Jan; 7(1):e00476. PubMed ID: 30345660
[TBL] [Abstract][Full Text] [Related]
17. Unusual clinical description of adult with Timothy syndrome, carrier of a new heterozygote mutation of CACNA1C.
Colson C; Mittre H; Busson A; Leenhardt A; Denjoy I; Fressard V; Troadec Y
Eur J Med Genet; 2019 Jul; 62(7):103648. PubMed ID: 30998997
[TBL] [Abstract][Full Text] [Related]
18. Generation of the human induced pluripotent stem cell line (IBKMOLi002-A) from PBMCs of a patient carrying the heterozygous L271H mutation of the voltage-gated calcium channel subunit Ca
Tisch M; Carmen De Mingo Alemany M; Suarez-Cubero M; Fauth C; Defrancesco M; Zschocke J; Günther K; Edenhofer F
Stem Cell Res; 2022 May; 61():102784. PubMed ID: 35453044
[TBL] [Abstract][Full Text] [Related]
19. Reprogramming of a human induced pluripotent stem cell line (ZZUSAHi004-A) from a long QT syndrome patient with a heterozygous AKAP9 (c. 4021C > A) mutant.
Ding T; Zhu W; Li X; Jian L
Stem Cell Res; 2022 Dec; 65():102966. PubMed ID: 36395689
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for the Study of Variant Pathogenicity: Validation of a
Gélinas R; El Khoury N; Chaix MA; Beauchamp C; Alikashani A; Ethier N; Boucher G; Villeneuve L; Robb L; Latour F; Mondesert B; Rivard L; Goyette P; Talajic M; Fiset C; Rioux JD
Circ Cardiovasc Genet; 2017 Oct; 10(5):. PubMed ID: 29021306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
